CD39 and CD73 enhance immune-evasive activities of tumor and stromal cells by impeding cytotoxic T cell function and NK cell cytotoxicity, but increasing Treg function via the degradation of immune stimulatory ATP to adenosine. This evidence concerns the gene ENTPD1 and neoplasm.